Inspired by wellness-conscious millennials’ desire for simple, wholesome snacks and…
Detection technology business Eluceda has received backing from the Biotechnology and Biological Sciences Research Council (BBSRC) in support of its collaboration with the University of York and the development of novel protein scaffolds for use in biosensors.
Eluceda’s patented E-Sens™ technology detects small molecules, DNA or pathogens in a wide range of specialist applications ranging from identifying counterfeit consumer goods to discovering bacteria within healthcare facilities.
The Impact Acceleration Award from the BBSR will support the next generation of E-Sens™ product developments, as they focus on the sensitivity of the latest detection molecule signatures and their ability to work across a broader range of liquids and materials.
Eluceda aims to revolutionise the portable counterfeit detection market with its suite of on-product and in-product authentication solutions from its R&D facility, based at the University of York. The business is currently working with several partners to roll-out E-Sens™ and sees a potential limited only by the imagination.
Ian Eastwood, chief technology officer at Eluceda, said: “Technology is essential to protecting goods from counterfeiters. The BBSR funding will play an important part in the development of the latest molecular probes and building their role in helping identify genuine products across a wide variety of different consumer goods.
“We are delighted to underpin our strong relationship with the University of York on this project and look forward to seeing these developments provide brands with a means to eradicate counterfeiting.”